Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Complement and its environmental determinants in the progression of human rheumatoid arthritis.

Bemis EA, Norris JM, Seifert J, Frazer-Abel A, Okamoto Y, Feser ML, Demoruelle MK, Deane KD, Banda NK, Holers VM.

Mol Immunol. 2019 Aug;112:256-265. doi: 10.1016/j.molimm.2019.05.012. Epub 2019 Jun 15.

2.

Evaluation of Targeting Efficiency of Joints with Anticollagen II Antibodies.

Lofchy LA, Vu VP, Banda NK, Ramirez JR, Smith WJ, Gifford G, Gaikwad H, Scheinman RI, Simberg D.

Mol Pharm. 2019 Jun 3;16(6):2445-2451. doi: 10.1021/acs.molpharmaceut.9b00059. Epub 2019 May 15.

PMID:
31091104
3.

Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55.

Gifford G, Vu VP, Banda NK, Holers VM, Wang G, Groman EV, Backos D, Scheinman R, Moghimi SM, Simberg D.

J Control Release. 2019 May 28;302:181-189. doi: 10.1016/j.jconrel.2019.04.009. Epub 2019 Apr 8.

PMID:
30974134
4.

The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a novel targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer mouse models.

Fridkis-Hareli M, Storek M, Or E, Altman R, Katti S, Sun F, Peng T, Hunter J, Johnson K, Wang Y, Lundberg AS, Mehta G, Banda NK, Michael Holers V.

Mol Immunol. 2019 Jan;105:150-164. doi: 10.1016/j.molimm.2018.09.013. Epub 2018 Dec 1.

PMID:
30513451
5.

Targeting of Liver Mannan-Binding Lectin-Associated Serine Protease-3 with RNA Interference Ameliorates Disease in a Mouse Model of Rheumatoid Arthritis.

Banda NK, Desai D, Scheinman RI, Pihl R, Sekine H, Fujita T, Sharma V, Hansen AG, Garred P, Thiel S, Borodovsky A, Holers VM.

Immunohorizons. 2018 Sep;2(8):274-295. doi: 10.4049/immunohorizons.1800053.

6.

Complement in the Initiation and Evolution of Rheumatoid Arthritis.

Holers VM, Banda NK.

Front Immunol. 2018 May 28;9:1057. doi: 10.3389/fimmu.2018.01057. eCollection 2018. Review.

7.

The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosis.

Okamoto T, Mathai SK, Hennessy CE, Hancock LA, Walts AD, Stefanski AL, Brown KK, Lynch DA, Cosgrove GP, Groshong SD, Cool CD, Schwarz MI, Banda NK, Thurman JM, Yang IV, Holers VM, Schwartz DA.

Am J Physiol Lung Cell Mol Physiol. 2018 Jul 1;315(1):L1-L10. doi: 10.1152/ajplung.00395.2017. Epub 2018 Mar 22.

8.

Modulation of Inflammatory Arthritis in Mice by Gut Microbiota Through Mucosal Inflammation and Autoantibody Generation.

Jubair WK, Hendrickson JD, Severs EL, Schulz HM, Adhikari S, Ir D, Pagan JD, Anthony RM, Robertson CE, Frank DN, Banda NK, Kuhn KA.

Arthritis Rheumatol. 2018 Aug;70(8):1220-1233. doi: 10.1002/art.40490. Epub 2018 Jul 2.

9.

Interaction of extremophilic archaeal viruses with human and mouse complement system and viral biodistribution in mice.

Wu L, Uldahl KB, Chen F, Benasutti H, Logvinski D, Vu V, Banda NK, Peng X, Simberg D, Moghimi SM.

Mol Immunol. 2017 Oct;90:273-279. doi: 10.1016/j.molimm.2017.08.009. Epub 2017 Aug 30.

10.

Deconstructing the Lectin Pathway in the Pathogenesis of Experimental Inflammatory Arthritis: Essential Role of the Lectin Ficolin B and Mannose-Binding Protein-Associated Serine Protease 2.

Banda NK, Acharya S, Scheinman RI, Mehta G, Takahashi M, Endo Y, Zhou W, Farrar CA, Sacks SH, Fujita T, Sekine H, Holers VM.

J Immunol. 2017 Sep 1;199(5):1835-1845. doi: 10.4049/jimmunol.1700119. Epub 2017 Jul 24.

11.

In Vitro and In Vivo Differences in Murine Third Complement Component (C3) Opsonization and Macrophage/Leukocyte Responses to Antibody-Functionalized Iron Oxide Nanoworms.

Wang G, Griffin JI, Inturi S, Brenneman B, Banda NK, Holers VM, Moghimi SM, Simberg D.

Front Immunol. 2017 Feb 15;8:151. doi: 10.3389/fimmu.2017.00151. eCollection 2017.

12.

Protein arginine deiminase 4 inhibition is sufficient for the amelioration of collagen-induced arthritis.

Willis VC, Banda NK, Cordova KN, Chandra PE, Robinson WH, Cooper DC, Lugo D, Mehta G, Taylor S, Tak PP, Prinjha RK, Lewis HD, Holers VM.

Clin Exp Immunol. 2017 May;188(2):263-274. doi: 10.1111/cei.12932. Epub 2017 Mar 9.

13.

Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo.

Chen F, Wang G, Griffin JI, Brenneman B, Banda NK, Holers VM, Backos DS, Wu L, Moghimi SM, Simberg D.

Nat Nanotechnol. 2017 May;12(4):387-393. doi: 10.1038/nnano.2016.269. Epub 2016 Dec 19.

14.

Activation of Human Complement System by Dextran-Coated Iron Oxide Nanoparticles Is Not Affected by Dextran/Fe Ratio, Hydroxyl Modifications, and Crosslinking.

Wang G, Chen F, Banda NK, Holers VM, Wu L, Moghimi SM, Simberg D.

Front Immunol. 2016 Oct 10;7:418. eCollection 2016.

15.

Mannan-Binding Lectin-Associated Serine Protease 1/3 Cleavage of Pro-Factor D into Factor D In Vivo and Attenuation of Collagen Antibody-Induced Arthritis through Their Targeted Inhibition by RNA Interference-Mediated Gene Silencing.

Banda NK, Acharya S, Scheinman RI, Mehta G, Coulombe M, Takahashi M, Sekine H, Thiel S, Fujita T, Holers VM.

J Immunol. 2016 Nov 1;197(9):3680-3694. Epub 2016 Oct 5.

16.

Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake.

Inturi S, Wang G, Chen F, Banda NK, Holers VM, Wu L, Moghimi SM, Simberg D.

ACS Nano. 2015 Nov 24;9(11):10758-68. doi: 10.1021/acsnano.5b05061. Epub 2015 Oct 21.

17.

A New Approach for the Treatment of Arthritis in Mice with a Novel Conjugate of an Anti-C5aR1 Antibody and C5 Small Interfering RNA.

Mehta G, Scheinman RI, Holers VM, Banda NK.

J Immunol. 2015 Jun 1;194(11):5446-54. doi: 10.4049/jimmunol.1403012. Epub 2015 Apr 27.

18.

Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum.

Banda NK, Mehta G, Chao Y, Wang G, Inturi S, Fossati-Jimack L, Botto M, Wu L, Moghimi SM, Simberg D.

Part Fibre Toxicol. 2014 Nov 26;11:64. doi: 10.1186/s12989-014-0064-2.

19.

High-relaxivity superparamagnetic iron oxide nanoworms with decreased immune recognition and long-circulating properties.

Wang G, Inturi S, Serkova NJ, Merkulov S, McCrae K, Russek SE, Banda NK, Simberg D.

ACS Nano. 2014 Dec 23;8(12):12437-49. doi: 10.1021/nn505126b. Epub 2014 Nov 26.

20.

Essential role for the lectin pathway in collagen antibody-induced arthritis revealed through use of adenovirus programming complement inhibitor MAp44 expression.

Banda NK, Mehta G, Kjaer TR, Takahashi M, Schaack J, Morrison TE, Thiel S, Arend WP, Holers VM.

J Immunol. 2014 Sep 1;193(5):2455-68. doi: 10.4049/jimmunol.1400752. Epub 2014 Jul 28.

21.

New insights into disease-specific absence of complement factor H related protein C in mouse models of spontaneous autoimmune diseases.

Mehta G, Ferreira VP, Skerka C, Zipfel PF, Banda NK.

Mol Immunol. 2014 Nov;62(1):235-48. doi: 10.1016/j.molimm.2014.06.028. Epub 2014 Jul 15.

22.

Analysis of the complement activation in mice.

Banda NK, Takahashi K.

Methods Mol Biol. 2014;1100:365-71. doi: 10.1007/978-1-62703-724-2_31.

PMID:
24218276
23.

Roles of adipocytes and fibroblasts in activation of the alternative pathway of complement in inflammatory arthritis in mice.

Arend WP, Mehta G, Antonioli AH, Takahashi M, Takahashi K, Stahl GL, Holers VM, Banda NK.

J Immunol. 2013 Jun 15;190(12):6423-33. doi: 10.4049/jimmunol.1300580. Epub 2013 May 6.

24.

Essential role of surface-bound complement factor H in controlling immune complex-induced arthritis.

Banda NK, Mehta G, Ferreira VP, Cortes C, Pickering MC, Pangburn MK, Arend WP, Holers VM.

J Immunol. 2013 Apr 1;190(7):3560-9. doi: 10.4049/jimmunol.1203271. Epub 2013 Feb 22.

25.

Human complement receptor 2 (CR2/CD21) as a receptor for DNA: implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE).

Asokan R, Banda NK, Szakonyi G, Chen XS, Holers VM.

Mol Immunol. 2013 Jan;53(1-2):99-110. doi: 10.1016/j.molimm.2012.07.002. Epub 2012 Aug 10.

26.

Potentially autoreactive naturally occurring transitional T3 B lymphocytes exhibit a unique signaling profile.

Liubchenko GA, Appleberry HC, Holers VM, Banda NK, Willis VC, Lyubchenko T.

J Autoimmun. 2012 Jun;38(4):293-303. doi: 10.1016/j.jaut.2011.12.005. Epub 2012 Feb 24.

27.

Role of C3a receptors, C5a receptors, and complement protein C6 deficiency in collagen antibody-induced arthritis in mice.

Banda NK, Hyatt S, Antonioli AH, White JT, Glogowska M, Takahashi K, Merkel TJ, Stahl GL, Mueller-Ortiz S, Wetsel R, Arend WP, Holers VM.

J Immunol. 2012 Feb 1;188(3):1469-78. doi: 10.4049/jimmunol.1102310. Epub 2011 Dec 28.

28.

Mannose-binding lectin-associated serine protease-1 is a significant contributor to coagulation in a murine model of occlusive thrombosis.

La Bonte LR, Pavlov VI, Tan YS, Takahashi K, Takahashi M, Banda NK, Zou C, Fujita T, Stahl GL.

J Immunol. 2012 Jan 15;188(2):885-91. doi: 10.4049/jimmunol.1102916. Epub 2011 Dec 12.

29.

Identification of a central role for complement in osteoarthritis.

Wang Q, Rozelle AL, Lepus CM, Scanzello CR, Song JJ, Larsen DM, Crish JF, Bebek G, Ritter SY, Lindstrom TM, Hwang I, Wong HH, Punzi L, Encarnacion A, Shamloo M, Goodman SB, Wyss-Coray T, Goldring SR, Banda NK, Thurman JM, Gobezie R, Crow MK, Holers VM, Lee DM, Robinson WH.

Nat Med. 2011 Nov 6;17(12):1674-9. doi: 10.1038/nm.2543.

30.

Mechanisms of mannose-binding lectin-associated serine proteases-1/3 activation of the alternative pathway of complement.

Banda NK, Takahashi M, Takahashi K, Stahl GL, Hyatt S, Glogowska M, Wiles TA, Endo Y, Fujita T, Holers VM, Arend WP.

Mol Immunol. 2011 Oct;49(1-2):281-9. doi: 10.1016/j.molimm.2011.08.021. Epub 2011 Sep 23.

31.

Complement activation by (auto-) antibodies.

Daha NA, Banda NK, Roos A, Beurskens FJ, Bakker JM, Daha MR, Trouw LA.

Mol Immunol. 2011 Aug;48(14):1656-65. doi: 10.1016/j.molimm.2011.04.024. Epub 2011 Jul 14. Review.

PMID:
21757235
32.

N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis.

Willis VC, Gizinski AM, Banda NK, Causey CP, Knuckley B, Cordova KN, Luo Y, Levitt B, Glogowska M, Chandra P, Kulik L, Robinson WH, Arend WP, Thompson PR, Holers VM.

J Immunol. 2011 Apr 1;186(7):4396-404. doi: 10.4049/jimmunol.1001620. Epub 2011 Feb 23.

33.

Essential role of complement mannose-binding lectin-associated serine proteases-1/3 in the murine collagen antibody-induced model of inflammatory arthritis.

Banda NK, Takahashi M, Levitt B, Glogowska M, Nicholas J, Takahashi K, Stahl GL, Fujita T, Arend WP, Holers VM.

J Immunol. 2010 Nov 1;185(9):5598-606. doi: 10.4049/jimmunol.1001564. Epub 2010 Sep 24.

34.

Complement activation pathways in murine immune complex-induced arthritis and in C3a and C5a generation in vitro.

Banda NK, Levitt B, Wood AK, Takahashi K, Stahl GL, Holers VM, Arend WP.

Clin Exp Immunol. 2010 Jan;159(1):100-8. doi: 10.1111/j.1365-2249.2009.04035.x. Epub 2009 Oct 19.

35.

Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice.

Banda NK, Levitt B, Glogowska MJ, Thurman JM, Takahashi K, Stahl GL, Tomlinson S, Arend WP, Holers VM.

J Immunol. 2009 Nov 1;183(9):5928-37. doi: 10.4049/jimmunol.0901826. Epub 2009 Oct 14.

36.

Adenovirus-mediated gene transfer of adiponectin reduces the severity of collagen-induced arthritis in mice.

Ebina K, Oshima K, Matsuda M, Fukuhara A, Maeda K, Kihara S, Hashimoto J, Ochi T, Banda NK, Yoshikawa H, Shimomura I.

Biochem Biophys Res Commun. 2009 Jan 9;378(2):186-91. doi: 10.1016/j.bbrc.2008.11.005. Epub 2008 Nov 21.

PMID:
19026984
37.

Initiation of the alternative pathway of murine complement by immune complexes is dependent on N-glycans in IgG antibodies.

Banda NK, Wood AK, Takahashi K, Levitt B, Rudd PM, Royle L, Abrahams JL, Stahl GL, Holers VM, Arend WP.

Arthritis Rheum. 2008 Oct;58(10):3081-9. doi: 10.1002/art.23865.

38.
39.

Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis.

Banda NK, Thurman JM, Kraus D, Wood A, Carroll MC, Arend WP, Holers VM.

J Immunol. 2006 Aug 1;177(3):1904-12.

40.

Intracellular IL-1 receptor antagonist type 1 inhibits IL-1-induced cytokine production in keratinocytes through binding to the third component of the COP9 signalosome.

Banda NK, Guthridge C, Sheppard D, Cairns KS, Muggli M, Bech-Otschir D, Dubiel W, Arend WP.

J Immunol. 2005 Mar 15;174(6):3608-16.

41.

Enhancement of collagen-induced arthritis in mice genetically deficient in extracellular superoxide dismutase.

Ross AD, Banda NK, Muggli M, Arend WP.

Arthritis Rheum. 2004 Nov;50(11):3702-11.

42.

Generation and characterization of mice transgenic for human IL-18-binding protein isoform a.

Fantuzzi G, Banda NK, Guthridge C, Vondracek A, Kim SH, Siegmund B, Azam T, Sennello JA, Dinarello CA, Arend WP.

J Leukoc Biol. 2003 Nov;74(5):889-96. Epub 2003 Aug 11.

PMID:
12960225
43.

Prevention of collagen-induced arthritis in mice transgenic for the complement inhibitor complement receptor 1-related gene/protein y.

Banda NK, Kraus DM, Muggli M, Bendele A, Holers VM, Arend WP.

J Immunol. 2003 Aug 15;171(4):2109-15.

44.

Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein.

Banda NK, Vondracek A, Kraus D, Dinarello CA, Kim SH, Bendele A, Senaldi G, Arend WP.

J Immunol. 2003 Feb 15;170(4):2100-5.

45.

Mechanisms of effects of complement inhibition in murine collagen-induced arthritis.

Banda NK, Kraus D, Vondracek A, Huynh LH, Bendele A, Holers VM, Arend WP.

Arthritis Rheum. 2002 Nov;46(11):3065-75.

46.

Depletion of CD34+ CD4+ cells in bone marrow from HIV-1-infected individuals.

Banda NK, Simon GR, Sipple JD, Terrell KL, Archer P, Shpall EJ, Akkina RK, Myers AM, Harrison GS.

Biol Blood Marrow Transplant. 1999;5(3):162-72.

47.

Diphtheria toxin A gene-mediated HIV-1 protection of cord blood-derived T cells in the SCID-hu mouse model.

Banda NK, Akkina RK, Terrell K, Shpall EJ, Tomczak J, Campain J, Claman H, Cagle L, Harrison GS.

J Hematother. 1998 Aug;7(4):319-31.

PMID:
9735863
48.

HIV-gp120 induced cell death in hematopoietic progenitor CD34+ cells.

Banda NK, Tomczak JA, Shpall EJ, Sipple J, Akkina RK, Steimer KS, Hami L, Curiel TJ, Singer Harrison G.

Apoptosis. 1997;2(1):61-8.

PMID:
14646565
49.

Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes.

Finkel TH, Tudor-Williams G, Banda NK, Cotton MF, Curiel T, Monks C, Baba TW, Ruprecht RM, Kupfer A.

Nat Med. 1995 Feb;1(2):129-34.

PMID:
7585008
50.

Indirect mechanisms of HIV pathogenesis: how does HIV kill T cells?

Finkel TH, Banda NK.

Curr Opin Immunol. 1994 Aug;6(4):605-15. Review.

PMID:
7946050

Supplemental Content

Loading ...
Support Center